| abstract |
the present invention provides a combination vaccine comprising one or more mycoplasma hyopneumoniae antigens, one or more porcine circovirus antigens, and pharmaceutically acceptable excipients and / or carriers, for use in the prevention and / or treatment of porcine and / or enzootic pneumonia diseases associated with porcine circovirus (pcvad) by the administration of the vaccine in the dermis of the herd, in which the one or more antigens of porcine circovirus comprises the pcv2 orf2 protein in an amount of 0.1 µg / dose at 10 µg / dose. |